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SuccinateWhether active UCP1 can reduce ROS production in brown-fat mitochondria is presently not settled. The issue is
of principal signiﬁcance, as it can be seen as a proof- or disproof-of-principle concerning the ability of any protein
to diminish ROS production through membrane depolarization. We therefore undertook a comprehensive
investigation of the signiﬁcance of UCP1 for ROS production, by comparing the ROS production in brown-fat
mitochondria isolated from wildtype mice (that display membrane depolarization) or from UCP1(−/−) mice
(with a high membrane potential). We tested the signiﬁcance of UCP1 for glycerol-3-phosphate-supported
ROS production by three methods (ﬂuorescent dihydroethidium and the ESR probe PHH for superoxide, and
ﬂuorescent Amplex Red for hydrogen peroxide), and followed ROS production also with succinate, acyl-CoA or
pyruvate as substrate. We studied the effects of the reverse electron ﬂow inhibitor rotenone, the UCP1 activity
inhibitor GDP, and the uncoupler FCCP. We also examined the effect of a physiologically induced increase in
UCP1 amount. We noted GDP effects that were not UCP1-related. We conclude that only ROS production
supported by exogenously added succinate was affected by the presence of active UCP1; ROS production
supported by any other tested substrate (including endogenously generated succinate) was unaffected.
This conclusion indicates that UCP1 is not involved in control of ROS production in brown-fat mitochondria.
Extrapolation of these data to other tissues would imply that membrane depolarization may not necessarily
decrease physiologically relevant ROS production. This article is a part of a Special Issue entitled: 18th
European Bioenergetics Conference (Biochim. Biophys. Acta, Volume 1837, Issue 7, July 2014).
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Published observations concerning the effect of UCP1 on ROS pro-
duction are not consistent, with data being interpreted as indicating
that the absence of UCP1 leads to increased ROS production [1,2] — or
that UCP1, even when active, has no effect on ROS production [3–5].
Whereas this issue is evidently of interest regarding brown
adipose tissue function, its signiﬁcance is broader than that. This is
because UCP1 is the only veriﬁed uncoupling protein: it does lead,6-dichlorophenolindophenol;
A, ethylenediamine tetraacetic
nylhydrazone; GDP, guanosine
phate dehydrogenase; GCCR,
, 1-hydroxy-4-phosphono-
gen species; SOD, superoxide
CP1, uncoupling protein 1
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eden. Tel.: +46 8 164120.to decreased membrane potential when it is active [6–8]. Provided
that ROS production is membrane-potential-sensitive, UCP1 should
undoubtedly inﬂuence ROS production.
In this way, UCP1 effects on ROS production may be said to be a
proof-of-principle test. It has been suggested [9], widely accepted [10]
but also critically discussed [11–13] that the members of the so-called
uncoupling protein family could be protective against oxidative
damage, based on their suggested uncoupling (depolarizing) activity.
However, as it may be doubted that any member of the uncoupling
protein family (UCP2, UCP3, protoUCP1) other than mammalian UCP1
itself has uncoupling activity [12,14], it is not appropriate presently to
examine this hypothesis in any tissue, except in the UCP1-expressing
brown adipose tissue. If UCP1 does not function as a mitigator of ROS
production in brown-fat mitochondria, the issue of developing possibil-
ities to activate other uncoupling protein-family members to induce an
uncoupling activity [15,16] becomes irrelevant as a means to diminish
ROS production and oxidative damage.
Furthermore, as active UCP1 undoubtedly reduces themitochondrial
membrane potential [12,14], a diminished ROS production must
unconditionally be observed when UCP1 is active if the so-called
2018 I.G. Shabalina et al. / Biochimica et Biophysica Acta 1837 (2014) 2017–2030“mild-uncoupling” hypothesis for amelioration of oxidative damage
is valid [17,18]. If this is not the case, themild-uncoupling hypothesis
would not provide a therapeutic pathway to protect against oxida-
tive damage. The issue of the actual signiﬁcance of oxidative damage
for the ageing process [19] – and for mitochondrial diseases [20] – is
outside the range of issues in the present paper.
As will be understood from the outline above, it is of considerable
importance to establish the actual ability of UCP1 to affect ROS produc-
tion. This is thus the aim of the present investigation.We conclude that,
with the exception of a very speciﬁc and probably not physiologically
related condition (exogenously added succinate respiration), we ﬁnd
no effect of UCP1 on ROS production in brown-fat mitochondria.
Concerning the possible function of uncoupling proteins andmembrane
potential in ameliorating ROS production in any tissue, our observations
would imply that such effects are unlikely, although dedicated
experiments would be needed to establish this in general.
2. Materials and methods
2.1. Animals
UCP1-ablated mice (progeny of those described in [21]) were
backcrossed to C57Bl/6 for 10 generations and after repeated
intercrossing (every 10 generations) were maintained as UCP1(−/−)
and UCP1(+/+) (wildtype) strains. The mice were fed ad libitum
(R70 Standard Diet, Lactamin), had free access to water, and were
kept on a 12:12 h light:dark cycle, routinely at normal (24 °C) animal
house temperature. Adult (8–12 week old) male mice were routinely
used for the experiments.
For the experiments on cold-acclimated animals, adult male
mice were divided into age-matched (7–8 week old) groups, one
per cage, and acclimated at 30 °C or at 4 °C during 4–6 weeks.
The experiments were approved by the Animal Ethics Committee
of the North Stockholm region.
2.2. Isolation of brown adipose tissue mitochondria
Mice were anaesthetised for 1 min with a mixture of 79% CO2
and 21% O2 and decapitated. The interscapular, periaortic, axillary, and
cervical brown-adipose tissue depots were pooled from 3 to 5 mice
and placed in ice-cold medium consisting of 250 mM sucrose, freed of
white fat and used for isolation of brown-fatmitochondria. Preparations
from wildtype and UCP1(−/−) mice (or warm- and cold-acclimated
wildtype mice) were generally made and run in parallel.
Brown-fat mitochondria were isolated as described in [22]. The
brown adipose tissuewasﬁnelymincedwith scissors and homogenized
in a Potter homogeniser with a Teﬂon pestle. Throughout the isolation
process, tissues were kept at 0–2 °C. Mitochondria were isolated by dif-
ferential centrifugation as follows. The homogenates were centrifuged
at 8 500 g for 10 min at 2 °C in a Beckman J2-21M centrifuge. The
resulting supernatant, containing ﬂoating fat, was discarded. The pellet
was resuspended in ice-cold medium containing 250 mM sucrose.
The resuspended homogenate was centrifuged at 800 g for 10 min,
and the resulting supernatant was centrifuged at 8 500 g for 10 min.
The resulting mitochondrial pellet was resuspended in 100 mM KCl,
20 mM K+-Tes (pH 7.2), 1 mM EDTA, 0.6% (w/v) fatty-acid-free BSA
and centrifuged again at 8 500 g for 10min. The ﬁnalmitochondrial pel-
lets were resuspended by hand homogenisation in a small glass
homogeniser in the same medium. The concentration of mitochondrial
protein was measured using ﬂuorescamine [23] with BSA as a standard.
2.3. Oxygen consumption
Oxygen consumption rates were monitored with a Clark-type
oxygen electrode (Yellow Springs Instrument Co., USA) in a sealed
chamber at 37 °C, as described [24]. Brown-fat mitochondria(0.25 mg protein/ml) were incubated in a medium consisting of
125 mM sucrose, 20 mM K+-Tes (pH 7.2), 2 mM MgCl2, 1 mM EDTA,
4 mM KPi, and 0.1% (w/v) fatty-acid-free BSA.
Respiratory activity of mitochondria was measured in the presence
of 5 mM pyruvate plus 3 mMmalate or of 50 μM palmitoyl-CoA plus 5
mM carnitine plus 3 mM malate or of 5 mM glycerol-3-phosphate
or of 5 mM succinate. The respiration was initiated by the addition of
substrate. Basal (i.e. UCP1-independent) respiration was determined
as the residual respiration following addition of (routinely) 1 mM
GDP (increased concentration up to 3 mM has no additional effect
(not shown)). Maximal oxygen consumption rates were obtained by
addition of FCCP to a ﬁnal concentration of 0.7–2.1 μM.
2.4. Measurement of mitochondrial membrane potential
Mitochondrial membrane potential measurements were performed
with the dye safranin O [25] under the same conditions as those used
for oxygen consumption. The changes in absorbance of safranin O
were followed at 37 °C in an Olis® modernized Aminco DW-2 dual-
wavelength spectrophotometer at 511–533 nm with a 3-nm slit. Olis
GlobalWorks™ software was used for recording and quantiﬁcation.
Calibration curves were made for each mitochondrial preparation
in K+-free medium and were obtained from traces in which the
extramitochondrial K+, [K+]out, was altered by addition of KCl in
a 0.1–500 mM ﬁnal concentration range, in the presence of 3 μM
valinomycin. The change in absorbance caused by each addition was
plotted against [K+]out and the intramitochondrial K+, [K+]in, was esti-
mated by extrapolation of the line to the zero uptake point, as described
[25]. The absorbance readings were used to calculate the membrane
potential (mV) by the Nernst equation according to: Δψ= 61 mV · log
([K+]in/[K+]out).
2.5. Mitochondrial superoxide production
Superoxide was measured using 2 methods: superoxide-induced
conversion of dihydroethidium (DHE) into ﬂuorescent 2-OH-ethidium
[26], and superoxide-induced conversion of the spin-trapping reagent
PPH (1-hydroxy-4-phosphono-oxy-2,2,6,6-tetramethyl-piperidine) [27].
Conversion of DHEwasmonitored with a Sigma spectroﬂuorometer
at 37 °C with an excitation wavelength of 495 nm and emission via a
narrow band pass ﬁlter at 570± 5 nm [28]; the narrow band pass ﬁlter
helps to increase the selectivity [26]. Detection of superoxide radical by
this method has earlier been conﬁrmed by inhibition of the ﬂuorescent
signal with exogenous superoxide dismutase and by observation of a
lowered signal in hSOD2-overexpressing mice [28].
The cyclic hydroxyl-amine PPH (Noxygen Science Transfer &
Diagnostics GmbH) was used for measurements of superoxide pro-
duction by mitochondria [29]. PPH reacts with superoxide, producing
stable PP-nitroxide that can be detected with electron spin resonance
(ESR) spectroscopy [27]. Brieﬂy, 10 mM PPH was dissolved in deoxy-
genatedmedium containing 50 μMdeferoxamine. Mitochondria prep-
arations and PPH stock solutions were kept on ice (50 μg protein
mixed with 1 mM PPH and mitochondrial substrates in 100 μl incu-
bation medium with the same composition as described for oxygen
consumption). Accumulation of PP-nitroxide was measured with a
Bruker ESP 300 X-band spectrometer and a super-high Q microwave
cavity. The following ESR settings were used: microwave frequency
9.78 GHz, modulation amplitude 2 G, microwave power 10 dB, con-
version time 1.3 s, and time constant 5.2 s.
2.6. Mitochondrial hydrogen peroxide production
MitochondrialH2O2 net productionwasdeterminedﬂuorometrically
with the Amplex Red reagent. Oxidation of Amplex Red coupled by
horseradish peroxidase to reduction of H2O2 produces the red ﬂuores-
cent product resoruﬁn. Mitochondria (0.05–0.12 mg mitochondrial
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used for oxygen consumption. All incubations also contained 5 μM
Amplex Red, 12 units ml−1 horseradish peroxidase and 45 units ml−1
superoxide dismutase. The reaction was routinely initiated by addition
of mitochondria followed by successive addition of substrate (as
described for oxygen consumption), followed by rotenone (0.7 μM)
or GDP (1 mM) or FCCP (actual concentrations indicated in ﬁgure
legends). In some experiments, substrates and GDP or rotenone
were added simultaneously. The increase in ﬂuorescence emitted
through a band pass ﬁlter of 600 ± 20 nm from an excitation wave-
length of 545 nm was followed in a 3 ml cuvette for 2–5 min with a
Sigma spectroﬂuorometer. In some experiments, ﬂuorescence was
detected with an EnSpire® Multimode Plate Reader (PerkinElmer,
USA) in 24-well plate. Optimisation was applied, the excitation
wavelength was set to 563 nm and the ﬂuorescence emission was
detected at 584 nm. The rate of H2O2 production was calculated as
the change in ﬂuorescence intensity during the linear increase
phase, as earlier described [8,30]. Calibration curves were obtained by
adding known amounts of freshly diluted H2O2 (the concentration of
stock solution was checked at 240 nm using a molar extinction coefﬁ-
cient of 43.6) to the assay medium. The standard curve was linear in
a range up till 500 nM H2O2. The calibration was performed also in the
presence of GDP, rotenone and all substrates used for this study; no ad-
ditions had any effect on the calibration. We speciﬁcally paid attention
to possible effects of glycerol-3-phosphate (DL-α-glycerolphosphate,
disodium salt, 95–99% of α-isomer), but in contrast to [31] we did not
observe any assay interference with 5–10 mM of this compound.
2.7. Immunoblotting
Immunoblot analysis was performed principally as in [32]. Aliquots
of freshly isolated mitochondrial suspensions were supplemented
with a protease inhibitor cocktail (Complete Mini, Roche), placed in
liquid nitrogen and then stored at −80 °C. Protein concentrations
of the thawed mitochondrial samples were re-quantiﬁed using the
Bradford assay. Mitochondrial proteins were analysed by Tricine SDS-
PAGE on 10% gels [33] using the Mini-Protean III apparatus (BioRad).
Proteins were transferred from gels to PVDF-membranes (Immobilon-P,
Millipore) using semidry electrotransfer (BioRad). The membranes
were blocked with 5% (w/v) non-fat dried milk in TBST (150 mM
NaCl, 10 mM Tris, 0.1% (v/v) Tween-20, pH 7.5) for 1 h and incubated
for 2 h with the speciﬁc primary antibodies diluted in TBST. A mono-
clonal antibody against subunit SDHA (70 kDa) of succinate dehy-
drogenase was obtained from Abcam; rabbit polyclonal antibodies
to glycerol 3-phosphate dehydrogenase (mGPDH) were custom pre-
pared [32]. The dilution of SDHA antibody was 1:2000. The dilution
of mGPDH antibody was 1:5000. Membranes were then incubated
for 1 h with corresponding secondary ﬂuorescent antibodies —
IRDye 680- or 800-conjugated goat anti-mouse IgG (Life Technolo-
gies) or goat anti-rabbit IgG (Rockland). Both secondary antibodies
(mouse and rabbit) were diluted 1:3000. Detection of proteins was
performed using an Odyssey ﬂuorescence scanner (Li-Cor). The
quantiﬁcation of signals was carried out in Aida Image Analyzer
programme version 3.21 (Raytest).
2.8. Enzyme activity assays
Activities of glycerol 3-phosphate dehydrogenase (mGPDH), glycerol-
3-phosphate cytochrome c reductase (mGPDH+Complex III; systematic
name, glycerol-3-phosphate:ferricytochrome c oxidoreductase; GCCR)
and succinate cytochrome c reductase (Complex II + Complex III; sys-
tematic name, succinate:ferricytochrome c oxidoreductase; SCCR) were
determined spectrophotometrically (Shimadzu UV-1601) in frozen-
thawed mitochondria as described [34]. 2,6-dichlorophenolindophenol
(DCPIP), electron acceptor for the dehydrogenase itself (mGPDH)
was monitored at 610 nm, molar absorption coefﬁcient ε610 =20.1 mM−1 · cm−1. Cytochrome c, electron acceptor for oxidoreduc-
tases (GCCR and SCCR)wasmonitored at 550 nm,molar absorption co-
efﬁcient ε550 = 19.6 mM−1 · cm−1. The assay medium contained
50 mM KCl, 10 mM Tris–HCl, 1 mM EDTA, 1 mg BSA ml−1, 1 mM KCN,
pH 7.4 and 100 μM DCPIP or 50 μM cytochrome c (from bovine heart)
and approximately 0.1 mg mitochondrial protein. The reaction was
started by addition of 10 mM sn-glycerol 3-phosphate or succinate,
and changes in absorbance were monitored at 30 °C. Enzyme activities
were expressed as nmol · min−1 · mg−1 protein.
2.9. Chemicals
Fatty-acid-free bovine serum albumin (BSA), fraction V, was
from Roche Diagnostics GmbH. Rotenone, FCCP (carbonyl cyanide p-
(triﬂuoromethoxy)-phenylhydrazone), GDP (guanosine 5′-diphos-
phate) (sodium salt), pyruvic acid (sodium salt), DL-α-glycerol-3-phos-
phate (disodium salt, 95–99% of α-isomer), succinic acid (disodium
salt), L(−) malic acid (disodium salt), palmitoyl coenzyme A (lithium
salt), xanthine (2,6-dihydroxypurine), xanthine oxidase, safranin O,
EDTA (ethylenediamine tetraacetic acid), bovine recombinant superox-
ide dismutase, horseradish peroxidase, alamethicin were all from
Sigma-Aldrich Co. Fluorescamine (4-phenyl spiro-[furan-2(3H),1-
phthalan]-3,3′-dione) was from Fluka Chemie GmbH. Amplex Red
and dihydroethidium were from Life Technologies. GDP was dis-
solved in 20 mM Tes (pH 7.2) and the pH of the solution readjusted
to 7.2. FCCP was dissolved in 95% ethanol and diluted in 50% ethanol;
oligomycin was dissolved in 95% ethanol. Ethanol in a ﬁnal concen-
tration of 0.1% did not in itself have any effects on the parameters
measured.
2.10. Statistics
All data are expressed asmeans± standard errors. Statistical analysis
was performed using KaleidaGraph 4.5.0 software, Student's t-test.
3. Results
The main aim of this investigation was to ascertain whether
the presence or absence of UCP1 affected the generation of ROS in
brown-fat mitochondria. Therefore, the experiments were basically
comparisons between ROS production in brown-fat mitochondria
isolated from wildtype or UCP1-ablated mice. The mice were housed
at 24 °C to provide a level of UCP1-mediated uncoupling that resulted
in a fairly modest reduction in membrane potential, “mild uncoupling”.
The experiments were initially performed in the absence of GDP,
i.e. UCP1 in the wildtype mitochondria is then innately active, which
is expected to lead to a physiologically relevant, lower membrane
potential and a high rate of oxygen consumption. The experiments
were performed with different substrates (glycerol-3-phosphate,
succinate, pyruvate and palmitoyl-CoA) and initially in the absence
of rotenone, i.e. reverse electron transport was possible.
3.1. No effect of UCP1 on glycerol-3-phosphate-supported ROS production:
veriﬁcation by three different methods
Glycerol-3-phosphate is a favoured experimental substrate for
brown-fat mitochondria, as compared not only to white- [35] and
brite-fat mitochondria [36] but also to mitochondria from most other
tissues [37]. The particular physiological role of glycerol-3-phosphate
in brown adipose tissue metabolism has not been fully established,
but mitochondrial glycerol-3-phosphate dehydrogenase activity is
probably associated with the transfer of reducing equivalents from the
cytosol to the mitochondria [38]. Due to the high activity of glycerol-
3-phosphate dehydrogenase in brown-fat mitochondria, it is relevant
to examine ROS production with glycerol-3-phosphate as substrate.
A) Oxygen consumption
UCP1(-/-)
UCP1(+/+)
X+XO+SOD
X+XO
B) Membrane potential C) DHE fluorescence D) Superoxide by DHE
E) EPS measurement F) PP-nitroxide signal G) Superoxide by PPH
H) Amplex Red + HRP I) Hydrogen peroxide 
Fig. 1. No effect of UCP1 on ROS production in mitochondria energized by glycerol-3-phosphate. (A, B) Rates of oxygen consumption and level of membrane potential in brown-fat
mitochondria from wildtype (UCP1(+/+)) and UCP1(−/−) mice. Respiration was supported by 5 mM glycerol-3-phosphate. These and all other experiments in this ﬁgure were
performed in the absence of GDP and rotenone, i.e. allowing for full innate activity of UCP1 and for reverse electron ﬂow. Data are means ± SE from 10 to 12 independent experiments;
* indicates difference between genotypes (two symbols indicate P b 0.01, three symbols indicate P b 0.001). (C) A representative trace of DHE ﬂuorescence (superoxide release rates)
measured in wildtype and UCP1(−/−) brown-fat mitochondria. Initial additions were 0.08 mg/ml brown-fat mitochondria and 5 mM glycerol-3-phosphate, DHE added as indicated.
(D) Change in DHE ﬂuorescence rate (measured principally as shown in C) in brown-fat mitochondria isolated from wildtype and UCP1(−/−) mice. Data are means ± SE from 3 to 4
independent experiments. (E)Measurement of superoxide with ESR and the spin probe PPH. PPH reacts with superoxide (obtained here from xanthine plus xanthine oxidase), producing
stable PP-nitroxide detected with ESR spectroscopy (orange signal, upper panel). The reaction was almost completely inhibited by 50 units/ml of superoxide dismutase (pink signal, upper
panel). To measure biologically produced superoxide we followed the middle peak (as indicated) of the ESR signal, as studied in brown-fat mitochondria from UCP1(−/−) (blue signal,
lower panel) and wildtype (red signal, lower panel) mitochondria. (F) Examples of changes of amplitude of the ESR signal (measured as in E (lower panel)) with time, followed in
brown-fat mitochondria preparations. (G) Rate of superoxide generation measured by ESR (as shown in E and F) in wildtype and UCP1(−/−) mitochondria. Data are means ± SE of
3–4 independent preparations. (H) A representative trace of Amplex Red ﬂuorescence (H2O2 levels) measured in wildtype and UCP1(−/−) brown-fat mitochondria. Additions were
0.03 mg/ml brown-fatmitochondria (Mit) and 5mMglycerol-3-phosphate (G3P). (I)Hydrogenperoxide production rate (measured principally as shown inH and expressed as hydrogen
peroxide amount, based on calibrations) in brown-fat mitochondria isolated from wildtype and UCP1(−/−) mice. Data are means of 10–12 independent preparations.
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oxidation. As seen in Fig. 1A,wildtypemitochondria demonstrated a high
rate of respirationwhichwas about double that observed in UCP1(−/−)
mitochondria; addition of GDP to wildtype mitochondria (Fig. 2A)
reduced respiration to the level seen in UCP1(−/−) mitochondria
(Fig. 2A and [24,39,40]). Concomitant with the difference in respiration
seen betweenwildtype and UCP1(−/−)mitochondria, a clear difference
in membrane potential was seen, with the membrane potential being
markedly higher in UCP1(−/−) mitochondria (Fig. 1B).
With regard to ROS production, we [3] and others [1] have earlier
demonstrated that despite this clear difference in membrane potential,
brown-fat mitochondria with or without UCP1 produce equal amounts
of superoxide. These earlier experiments were conducted in the
presence of rotenone, and reverse electron ﬂow was thus inhibited.
There is therefore a possibility that under conditions of unmanipulated
electron ﬂow through the respiratory chain, a UCP1 effect on ROSproduction could become unveiled. Therefore here, brown-fat mito-
chondria were incubated without rotenone, to allow for reverse
electron ﬂow and therefore for superoxide generation possibly sensitive
to membrane potential/proton motive force (Fig. 1C-I).
As it is recurrently discussed whether different methods for detect-
ing ROS could yield different results, we used three different methods
for ROS detection under otherwise similar circumstances.
3.1.1. Dihydroethidium
First, net superoxide release rates were assessed in isolated brown-
fat mitochondria by following the ﬂuorescence of OH-ethidium, which
is generated when superoxide interacts with the dye dihydroethidium
(DHE). Chemical and biological validation of this method has been
performed earlier with brown-fat mitochondria [28]. In the present
experiments, we found that wildtype brown-fat mitochondria
incubated with glycerol-3-phosphate showed a linear increase in
Fig. 2. Bioenergetic parameters of wildtype brown-fat mitochondria, a comparison of
glycerol-3-phosphate or succinate as substrate. (A, B) Representative recordings from
oxygen consumption (A) and membrane potential (B) measurements of brown-fat
mitochondria isolated from wildtype mice. Mitochondria were supported by either
5 mM glycerol-3-phosphate (red line) or 5 mM succinate (black line). Additions
were 0.25 mg mitochondria (Mit), substrates (subs), 1 mM GDP and 0.7–2.1 μM
FCCP (added successively) for glycerol-3-phosphate in A, 0.7 μM FCCP (single addition)
for succinate in A and for both substrates in B, and 0.02 mg/ml alamethicin (Ala)
(to allow for full de-energization). Note that no rotenone was present. To allow for direct
comparisons, all parameters shown are from one experimental day, with parallel
preparations of glycerol-3-phosphate and succinate, examined in parallel for respiration,
membrane potential and hydrogen peroxide release. (C) Hydrogen peroxide production
rate (measured principally as in Fig. 1H) in wildtype brown-fat mitochondria supported
either by 5 mM glycerol-3-phosphate or by 5 mM succinate. Values are means ± SE
of 5 independent mitochondrial preparations analysed in parallel on two sub-
strates. ***: statistically signiﬁcant difference between glycerol-3-phosphate and
succinate (P b 0.001).
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brown-fatmitochondria fromUCP1(−/−)micewas similar. A compila-
tion of the results from a series of such experiments indicated an
identical rate of superoxide formation in wildtype and UCP1(−/−)
mitochondria (Fig. 1D). Thus, even in the absence of rotenone, we
could not observe any effect of UCP1 on ROS production,when followed
in this way.3.1.2. Electron spin resonance spectroscopy
We also used the spin probe PPH (1-hydroxy-4-phosphono-oxy-
2,2,6,6-tetramethyl-piperidine) to follow superoxide production.
This method for superoxide detection may be considered more
speciﬁc than the dihydroethidium method (where other substances
than superoxidemay interfere [26]). Validation of this assay of superox-
ide radicals was performed with a superoxide (O2•−)-generating system
(xanthine+ xanthine oxidase). The chemical generation of superoxide
by the xanthine plus xanthine oxidase system resulted in a signiﬁcant
PP-nitroxide formation (Fig. 1E, upper panel). This was blocked by the
addition of recombinant superoxide dismutase (Fig. 1E, upper panel),
demonstrating the speciﬁcity of the signal. This method was then
applied for comparison of superoxide production in brown-fat mito-
chondria from wildtype and UCP1(−/−) mice; superoxide was clearly
detectable (Fig. 1E, lower panel). As seen in the example in Fig. 1F,
the amplitude of the signal increased similarly with time in both types
of mitochondria. Thus, also with this method, no effect of UCP1 on
ROS generation was observable (Fig. 1G).
3.1.3. Amplex Red
ROS production may alternatively be followed as release of
hydrogen peroxide, which can be monitored with the dye Amplex
Red. Also here, ROS production was linear with time in bothwildtype
and UCP1(−/−) mitochondria (Fig. 1H), and no statistical difference
in hydrogenperoxide production could be observeddue to the presence
or absence of UCP1 (Fig. 1I). It may be noted that there was no ROS pro-
duction from endogenous substrates.
Thus, based on congruent results from three independent assays for
ROS production,we conclude that the presence or absence of UCP1 does
not inﬂuence ROS production supported by glycerol-3-phosphate. This
is thus still the case evenwhen reverse electronﬂow is possible, perhaps
because most glycerol-3-phosphate-supported ROS production occurs
within the enzyme itself (see below).
3.2. Succinate is a poor substrate for brown-fat mitochondria
In studies on the control of mitochondrial ROS production in any
tissue, ROS production has primarily been examined with the complex
II-coupled substrate succinate. Succinate reduces ubiquinone (Q) and
generates a proton-motive force that is sufﬁciently high to drive
electrons thermodynamically uphill through complex I to reduce
NAD+ to NADH (i.e. reverse electron ﬂow), resulting in superoxide
production from a not fully clariﬁed site, probably from semi-
reduced coenzyme Q (semiquinone) at the coenzyme Q-binding site
of complex I [41,42]. As both succinate and glycerol-3-phosphate dehy-
drogenases deliver electrons to coenzymeQ,wewanted to examine the
inﬂuence of UCP1 on succinate-supported ROS production, in compari-
son with glycerol-3-phosphate-supported ROS production.
First, the functionality of isolated brown-fat mitochondria respiring
on glycerol-3-phosphate versus succinate was examined (Fig. 2A and
B) in classical bioenergetic experiments. As seen in Fig. 2A, wildtype
brown-fat mitochondria responded to glycerol-3-phosphate addition
with a large increase in respiration that was inhibitable by the UCP1
inhibitor GDP; respiration could be re-induced with FCCP. In contrast
to glycerol-3-phosphate, succinate was a poor substrate for brown-fat
mitochondria and unable to support a high rate of oxygen consumption
(Fig. 2A), as pointed out earlier [5,7,36]. Based solely on succinate oxida-
tion rates, no evidence for any role of UCP1 in brown-fat mitochondrial
bioenergetics can (apparently) be observed (no effect of GDP or FCCP
(Fig. 2A)). This misleading conclusion is presumably mainly due to a
low capacity of the succinate transporter [43,44], although under
these conditions, oxaloacetatemay also exert inhibitory action on succi-
nate dehydrogenase.
The results concerning the membrane potential were different. We
assessedmembrane potential by safranin O absorbance inmitochondria
respiring on glycerol-3-phosphate or succinate (Fig. 2B). The addition of
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membrane potential, with inhibition of UCP1 activity by GDP leading
to a further increase. The addition of succinate led to a much smaller
but still measurable increase in membrane potential, smaller probably
because the ability of the brown-fat mitochondria to oxidise succinate
was so low (Fig. 2A) that the respiratory chain proton pumping could
not counteract the backﬂow of protons through UCP1. However, when
UCP1 activity was inhibited by GDP, the pumping capacity wasFig. 3.UCP1 has effect only on succinate-supported ROS production. (A) Effect of UCP1-ablation
wildtype and UCP1(−/−) brown-fat mitochondria (measured principally as in Fig. 1H). To ma
wildtype andUCP1(−/−)micewere isolated and analysed in parallel, examinedwith both glyc
mitochondria was expressed as 100% and the rate in UCP1(−/−) was expressed as percentage
genotype. (B, C, D) Effects of FCCP (B), rotenone (C) and GDP (D) on relative H2O2 production ra
3-phosphate and succinate as substrate. FCCP (0.7 μM)or rotenone (0.7 μM)orGDP (1mM)was
day, the rate of hydrogen peroxide production on each substrate was expressed as 100% and th
this. Values are means ± SE of 3–5 independent mitochondrial preparations for each genotyp
supported by 5mM glycerol-3-phosphate (E) or 5 mM succinate (F) measured principally as in
for each genotype. For all these panels, * indicates statistically signiﬁcant differences between w
rotenone or GDP) and $ statistically signiﬁcant differences between substrates used. One symbsufﬁcient to raise the membrane potential nearly to the fully coupled
level. Thus, despite the low rate of succinate oxidation, the membrane
potential of the brown-fat mitochondria could still be increased signiﬁ-
cantly when UCP1 was not active.
In these wildtype brown-fat mitochondria (where UCP1 activity
is rather high), a much lower rate of ROS production was observed
with succinate than with glycerol-3-phosphate (Fig. 2C). This is again
probably due in part to the limitations caused by the low capacity ofon rate of H2O2 production supported by 5mMglycerol-3-phosphate or 5mM succinate in
ke this direct comparison we only used data from experiment where mitochondria from
erol-3-phosphate and succinate as substrate. Themean rate of H2O2 production inwildtype
of this. The values are means ± SE of 5 independent mitochondrial preparations for each
tes inwildtype andUCP1(−/−) brown-fatmitochondria; a comparison between glycerol-
added following substrate addition or simultaneouslywith substrate. For eachpreparation
e rate after addition in the same trace or in parallel traces was expressed as percentage of
e. (E, F) Membrane potential levels in wildtype and UCP1(−/−) brown-fat mitochondria
Fig. 2B. The values represent means ± SE of 3–5 independent mitochondrial preparations
ildtype and UCP1(−/−) mitochondria, # statistically signiﬁcant effect of additions (FCCP,
ol indicates P b 0.05, two symbols indicate P b 0.01, and three symbols indicate P b 0.001.
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substantially higher [8]. Since glycerol-3-phosphate is oxidised on the
outside of the mitochondria, no transport limitations are relevant for
this substrate. In addition direct ROS formation by the glycerol-3-phos-
phate dehydrogenase may also contribute to high ROS production rate
[37].
3.3. UCP1-dependent ROS production in brown-fat mitochondria under
classical conditions of ROS assessment
We proceeded to investigate the UCP1-dependence and further
characteristics of succinate- versus glycerol-3-phosphate-supported
ROS production (Fig. 3). For simple comparisons, and because the
wildtype ROS production rates were so different with the two sub-
strates, we have expressed the effects relative to the rates in wildtype
mitochondria.
In contrast towhatwas the case for glycerol-3-phosphate-supported
ROS production – that was unaffected by the presence or absence of
UCP1 (Figs. 1D, G and 3A) – we found a marked effect of UCP1-
ablation on succinate-supported ROS production (Fig. 3A). The higher
membrane potential in UCP1-ablated mitochondria (Fig. 3F) was thus
associated with nearly a tripling of ROS production.
In support of the succinate-driven higher ROS production in
UCP1(−/−)mitochondria being due to the highermembrane potential,
dissipation of the membrane potential with FCCP was associated with
an almost complete elimination of succinate-supported ROS production
(Fig. 3B). Notably, this FCCP effect was also evident in wildtype mito-
chondria that are generally considered to be innately “uncoupled”.
However, as demonstrated in Figs. 2B and 3F, succinate was able to
build up some membrane potential even in the wildtype mitochondria
thatwere thus uncoupledwithout being totally de-energized—whereas
FCCP addition leads to a full de-energization (Fig. 2B), probably
explaining the inhibition of ROS production even in the wildtype mito-
chondria. These observations on succinate-supported ROS production
in brown-fat mitochondria are fully in accordance with what would be
expected based on classical data obtained with mitochondria from
other tissues, demonstrating that succinate-supported ROS production
is highly sensitive to changes in membrane potential [45,46], reviewed
in [17,41,42].
There was also a small tendency to an inhibition of glycerol-3-
phosphate-supported ROS production by de-energization with
FCCP (Fig. 3B). This may imply that a small fraction of glycerol-3-
phosphate-supported ROS production also occurs through membrane-
potential-dependent reverse electron ﬂow (see below); the reason
that this is not visible as an effect of the presence or absence of UCP1
would be the same as that for succinate: that even in the presence of ac-
tive UCP1, a fairly highmembrane potential is reached (Figs. 2B and 3E).
To more directly examine the signiﬁcance of reverse electron
ﬂow for ROS production from succinate or glycerol-3-phosphate, we
examined the effect of rotenone (Fig. 3C). Rotenone inhibits complex I
at subunit ND1 [47] and through this it eliminates reverse electron
transport. We found, as expected from other tissues, that a substantial
part of succinate-supported ROS production was inhibited by rotenone
and thus was due to reverse electron ﬂow. Therewas amarkedly small-
er effect of rotenone on glycerol-3-phosphate-supported ROS produc-
tion (Fig. 3C) and the effect was thus comparable to the effect of FCCP
(Fig. 3B). Taken together, these data thus imply that the major part of
glycerol-3-phosphate-supported ROS production is not due to reverse
electron transport, but also that a small fraction is indeed due to reverse
electron transport, principally in agreement with observations in [31].
To further examine the signiﬁcance of UCP1 activity on ROS produc-
tion, we analysed the effect of the UCP1 inhibitor GDP. As expected,
therewas no effect of GDP onROS production inUCP1(−/−)mitochon-
dria with either substrate (Fig. 3D), in accordance with an absence of
effect on membrane potential (Fig. 3EF). In accordance with expecta-
tions and with the data in Fig. 3A, inhibition of UCP1 activity by GDPled to a large stimulation of succinate-dependent ROS production
(Fig. 3D), explainable by an increase in membrane potential (Fig. 3F).
Unexpectedly, GDP also increased glycerol-3-phosphate-supported
ROS production (Fig. 3D), an observation that does not immedi-
ately concur with the absence of effect of UCP1 ablation (Figs. 1D, G,
I and 3A). Indeed, the observation that the ROS production rate was
higher than in UCP1(−/−) mitochondria (Fig. 3D) cannot be explained
by an even higher membrane potential being observed in GDP-
inhibited mitochondria than in UCP1-ablated mitochondria (Fig. 3E).
Thus, the effect of GDP here may be of a different nature (see below).
It is clear from Figs. 1–3 that the magnitude of ROS production
observed with succinate as compared to glycerol-3-phosphate is much
lower: succinate generated about 10% of the ROS obtained from
glycerol-3-phosphate. However, it is also clear that qualitatively
remarkably different results were obtained when succinate or glycerol-
3-phosphatewas examined, yielding contrasting conclusions concerning
the signiﬁcance of membrane potential for ROS production. The conclu-
sion remains that UCP1 does not affect glycerol-3-phosphate-supported
ROS production but does notably affect succinate-supported ROS pro-
duction, when succinate is presented as an externally added substance.
3.4. No effect of UCP1 on glycerol-3-phosphate dehydrogenase and
succinate dehydrogenase amounts and activities
The possibility may be raised that some of the difference in ROS pro-
duction observed between wildtype and UCP1(−/−) mitochondria
(e.g. Fig. 3A) could be explained by an alteration in the levels of the
enzymes responsible. In Fig. 4, we have examined the effect of UCP1
ablation on the protein levels and the enzyme activities of both
glycerol-3-phosphate and succinate dehydrogenase systems. We saw
no effect of UCP1 ablation on any of these parameters (Fig. 4).
3.5. No effect of UCP1 on ROS production supported by physiologically
relevant substrates (fatty acid/pyruvate)
Although succinate is a favourite substrate for ROS production
studies, externally added succinate is not a physiologically relevant
substrate for brown-fat mitochondria (hardly for any mitochondria).
We therefore examined ROS production with more physiologically
relevant substrates. Brown-fat mitochondria are normally energized
mainly with fatty acids (supplying reducing equivalents from
β-oxidation to complex I and to electron transferring ﬂavoprotein-
ubiquinone reductase) and with pyruvate (supplying reducing
equivalents to complex I). For both substrates, there is good reason
to believe that oxidation (in the presence of malate) proceeds through
the citric acid cycle, and this means that physiologically relevant
succinate oxidation will also take place and inﬂuence observed ROS
production rates. Both fatty acids and pyruvate support UCP1-
dependent changes in oxygen consumption andmembrane potential
in brown-fat mitochondria in a way reﬂecting naturally regulated
uncoupling [7,24,36].
To examine the signiﬁcance of UCP1 for ROS production with these
physiologically relevant substrates, brown-fat mitochondria were
allowed to respire on palmitoyl-CoA + carnitine + malate (Fig. 5A–D)
or pyruvate + malate (Fig. 5E), and ROS production was measured.
As seen in Fig. 5AB, fatty acid-supportedROS productionwas observ-
able in both wildtype and UCP1(−/−) mitochondria, although the rate
was much lower than that for glycerol-3-phosphate-supported ROS
production (Fig. 1I). Again, despite the membrane potential being
lower in the wildtype than in the UCP1(−/−) mitochondria (Fig. 5D),
ROS production rates were unaffected by the presence or absence of
active UCP1 (Fig. 5AB).
We further added rotenone to the mitochondria. The addition of
rotenone increased ROS production in both wildtype and UCP1(−/−)
mitochondria (Fig. 5AB) to a similar degree. Thus, both endogenous
fatty acid-supported ROS production and inhibitor-enhanced,
Western blot
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Fig. 4. No effect of UCP1 ablation on glycerol-3-phosphate dehydrogenase and succinate
dehydrogenase levels and activities. (A) Western blot analyses of glycerol-3-phosphate
dehydrogenase (mGPDH) and the subunit SDHA (70 kDa) of succinate dehydrogenase
in wildtype and UCP1(−/−) brown-fat mitochondria. 3 or 6 μg of protein was loaded
as indicated. (B) Relative concentrations of mitochondrial proteins. Western blots as in
A were quantiﬁed. The mean level of each protein in wildtype mitochondria was set to
100% and the levels of this protein in othermitochondria expressed relative to this. Values
are means ± SE of 5 independent mitochondrial preparations in each group, analysed in
duplicate. (C) Activities of glycerol-3-phosphate dehydrogenase (mGPDH) and succinate
cytochrome c reductase (SCCR) in wildtype and UCP1(−/−) brown-fat mitochondria.
Means as in (B).
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UCP1 and the ensuing decreased membrane potential.
To further examine the signiﬁcance of UCP1 activity for ROS produc-
tionwith fatty acid substrates, we analysed the effect of the UCP1 inhib-
itor, GDP. As seen in Fig. 5C, GDP increased the rate of ROS production in
wildtype brown-fat mitochondria, as would indeed be expected if ROS
production was inﬂuenced bymembrane potential. However, the effect
of GDP on membrane potential was not higher than the effect of UCP1
ablation (Fig. 5D) (that did not affect ROS production), so there wasno simple relationship between membrane potential and ROS produc-
tion in this case. Even more remarkable, there was a clear stimulation
of ROS production by GDP in UCP1(−/−) mitochondria (evidently
without any effect on membrane potential (Fig. 5D)), making it clear
that this GDP effect was unrelated to its inhibition of UCP1 activity.
Rather, we would suggest that UCP1-independent GDP effects on ROS
production may occasionally be observed. We do not know the nature
of such effects; however, there is no reason to think that they are related
to any uncoupling protein activity, as we have also seen such effects in
liver mitochondria (not shown), i.e. in mitochondria that totally lack
any of the so-called uncoupling proteins.
Also pyruvate is a good complex-I substrate for supporting thermo-
genesis in brown-fat mitochondria [7,24,36]. ROS production was low
(Fig. 5E), the lowest observed with any of the substrates examined
here. Pyruvate exhibits some capacity to scavenge ROS [48], and this
could be a reason that ROS appeared lower than with fatty acid sub-
strate. We did not observe any effect of UCP1 on pyruvate-supported
ROS production, and similar to what was the case for fatty acid-
supported ROS production, rotenone increased ROS production, again
to the same extent in wildtype and UCP1(−/−) mitochondria (Fig. 5E).
Thus, with physiologically relevant substrates, we ﬁnd no evidence
that the presence of active UCP1 affects ROS production. As the total
oxidation process in the mitochondria would include the oxidation of
succinate in the citric acid cycle, the data also imply thatwhen succinate
is generated in the mitochondria as part of the physiologically relevant
oxidation process, there is no measurable effect of the presence or
absence of UCP1 on endogenous-succinate-supported ROS production.
3.6. Cold acclimation induces increased uncoupling but concurrently high
ROS production
To directly study the relation between UCP1 amount and ROS pro-
duction rate, we examined ROS production in brown-fat mitochondria
isolated from warm-acclimated and cold-acclimated mice (Fig. 6).
As compared to mitochondria from warm-acclimated (30 °C) mice,
mitochondria from cold-acclimated (4 °C) mice possess about 3-fold
higher amounts of UCP1 [7,36]. This difference is reﬂected in the
mitochondrial membrane potential being much higher in the warm-
acclimated than in the cold-acclimated mitochondria, both when
palmitoyl-CoA and when glycerol-3-phosphate were used as substrates
(Fig. 6A and D). Despite these large differences in UCP1 amount and
membrane potential, ROS production rates supported by palmitoyl-
CoA were identical in mitochondria from warm-acclimated and cold-
acclimated mitochondria (Fig. 6B), also after the addition of rotenone
(cold acclimation does not alter the concentration of complex I in
brown-fat mitochondria [36]). There was a stimulatory effect of GDP
on ROS production in both types of mitochondria (Fig. 6C), an effect
that could have been ascribed to inhibition of UCP1 activity by GDP
and an ensuing higher membrane potential. However, the effect of
GDP was higher in the warm-acclimated than in the cold-acclimated
mitochondria (Fig. 6C), which is the opposite of what would be ex-
pected if the effect was due to inhibition of UCP1. We therefore
also here suggest that GDP effects observed in these and other
types of mitochondria are not (necessarily) due to UCP1 inhibition.
Concerning glycerol-3-phosphate-supported ROS production, accli-
mation to cold was associated with a higher and not lower rate, as
would have been expected if UCP1 activity was protective against ROS
production (Fig. 6E). Also in these mitochondrial preparations,
inhibition of ROS production by rotenone implied that some part
of the ROS originated from reverse electron ﬂow (as implied above
(Fig. 3)). The effect of GDP addition was similar in the two types of
preparations (+21 ± 5% in mitochondria from warm- and +29 ± 9%
inmitochondria fromcold-acclimatedmice; not shown), again indicating
that the GDP effect is probably not related to UCP1 activity.
As one possible cause of the increased ROS production in cold-
acclimated mitochondria, we examined whether the activity of the
Fig. 5. No effect of UCP1 on ROS production from complex-I-linked substrates. (A) A representative trace of Amplex Red ﬂuorescence measured in wildtype and UCP1(−/−) brown-fat
mitochondria. Successive additions were 0.08 mg/ml brown-fat mitochondria (Mit), 5 mM carnitine, 50 μMpalmitoyl-CoA and 0.7 μM rotenone. Note that these experiments are initially
run in the absence of GDP and rotenone; thus, neither UCP1 activity nor forward electron ﬂow is inhibited. (B) ROS production (measured principally as shown in A and expressed as
hydrogen peroxide amount, based on calibrations) in brown-fat mitochondria isolated from wildtype and UCP1(−/−) mice. In this panel and the following ones, values are
means ± SE of 4 independent mitochondrial preparations of each genotype; statistics are as in Fig. 3. (C) Comparison of effects of 1 mM GDP on relative H2O2 production
rates in wildtype and UCP1(−/−) brown-fat mitochondria supported by 50 μM palmitoyl-CoA plus 5 mM carnitine. GDP was added following substrate addition, principally
as shown for rotenone in (A). The rate of hydrogen peroxide production supported by substrate was expressed as 100% and the rate after GDP addition from the same trace
was expressed as percentage of this. (D) Membrane potential level in wildtype and UCP1(−/−) brown-fat mitochondria supported by 50 μMpalmitoyl CoA plus 5 mM carnitine,
measured principally as in Fig. 2B. (E) ROS production rate (measured principally as shown in A but after addition of malate instead of carnitine and pyruvate instead of
palmitoyl-CoA) in brown-fat mitochondria isolated from wildtype and UCP1(−/−) mice.
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cold acclimation. We observed nearly a doubling of the activity of this
system (Fig. 6F), in agreement with our earlier observations [49]. We
therefore ﬁnd it probable that the increased ROS production in
the cold with glycerol-3-phosphate as substrate reﬂects the higher
amount of the dehydrogenase system in itself and has nothing to do
with UCP1 activity (where, as said, the opposite relation would have
been expected).4. Discussion
The present study addressed the issue whether UCP1 regulates ROS
production. The answerwas qualitatively dependent on the experimental
approach used. Under standard conditions for examining ROS production,
i.e. with reverse electron ﬂow from exogenously added succinate, UCP1
activity led to diminished ROS production. However, with physiologically
relevant substrates, representing lipid and carbohydrate oxidation, ROS
D)  Membrane potential
A)  Membrane potential B) ROS, palmitoyl-CoA C) ROS, Effect of GDP
E) ROS, G3P F) GCCR activity
Fig. 6. Effect of increased UCP1 levels on ROS production. In each panel, comparisons were made between brown-fat mitochondria isolated from wildtype mice acclimated to either
thermoneutrality (30 °C) or to cold (4 °C). (A, D) Representative recordings from membrane potential measurements of brown-fat mitochondria supported by palmitoyl-CoA plus
carnitine (A) or by glycerol-3-phosphate (D). Additions were 0.25 mg mitochondria (Mit), 50 μM palmitoyl CoA (PalmCoA) (5 mM carnitine was already present in the medium) or 5
mM glycerol-3-phosphate (G3P), 2 mM GDP, 1.4 μM FCCP and 0.02 mg/ml alamethicin (Ala). (B, E) ROS production rates (measured principally as shown in Figs. 1H and 5A). Values
here and in (C) and (F) are means ± SE from 3 to 5 independent mitochondrial preparations for each environmental temperature. (C) Comparison of effects of 1 mM GDP on relative
ROS production rates in brown-fat mitochondria supported by 50 μM palmitoyl-CoA plus 5 mM carnitine. GDP was added following substrate addition, principally as in Fig. 5A and C.
(F) Activities of glycerol 3-phosphate cytochrome c reductase (GCCR) in brown-fatmitochondria. *: statistically signiﬁcant difference betweenmitochondria isolated frommice acclimated
at 30 °C versus 4 °C temperatures; #: statistically signiﬁcant effect of additions (rotenone or GDP). One symbol indicates P b 0.05, two symbols indicate P b 0.01.
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may not only be of signiﬁcance for understanding the ROS issues of
brown adipose tissue. If extrapolation to other tissues is allowed, our re-
sults may have an important bearing on the physiological relevance
of the “mild uncoupling” hypothesis for protection against oxidative
damage, and particularly on the hypothesis that oxidative damage may
be prevented by activation of members of the uncoupling protein family.
The implication from the present experimentswould be that activation of
uncoupling proteins and decreases of mitochondrial membrane potential
may not be feasible avenues for decreasing ROS production and oxidative
damage. However, dedicated experiments would be needed to prove the
generality of our observations.
4.1. The singular substrates and ROS production
As implied above, the relationship between UCP1 activity, mem-
brane potential and ROS production is different depending on the
experimental system studied, particularly which substrate is used to
support mitochondrial respiration and thus ROS production. These sub-
strates will therefore be discussed separately.
4.1.1. Glycerol-3-phosphate
We found no effect of the presence or activity of UCP1 on glycerol-3-
phosphate-supported ROS production. These results expand thosereported by us [3] and others [1] demonstrating that despite a clear
difference in membrane potential levels, brown-fat mitochondria with
or without UCP1 produce equal amounts of superoxide, as determined
by the DHE method. The earlier experiments were conducted in the
presence of rotenone, and reverse electron ﬂow was thus inhibited.
The absence of effect of uncoupling on ROS was therefore as expected,
as discussed above. However, the continued absence of UCP1 effect
even in the absence of rotenone would indicate that reverse electron
ﬂow is not important for glycerol-3-phosphate-supported ROS produc-
tion. This in turn is in agreement with our observations of only a small
inhibitory effect of either rotenone or FCCP on glycerol-3-phosphate-
supported ROS production. This low but existing ROS production from
reverse electron ﬂow is in agreement with what has been suggested
[2,31]. The reason that FCCP has an inhibitory effect but UCP1 has not
may be understood as reﬂecting the only limited decrease inmembrane
potential observed fromUCP1 activity (Fig. 1B), as compared to the total
de-energisation introduced by FCCP (Fig. 2B) in these mitochondria
from 24 °C-acclimated mice with limiting UCP1 capacity.
Thus, we adhere to the idea that the main part of glycerol-3-
phosphate-supported ROS production in brown-fat mitochondria
comes directly from the glycerol-3-phosphate-dehydrogenase com-
plex itself or its interaction with coenzyme Q [50,51], rather than
from activity elsewhere in the respiratory chain. It may thus accu-
rately be said that a membrane potential effect cannot be expected
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that case the possibility of diminishing ROS production and oxidative
damage through membrane depolarization becomes untenable.
The ROS production we observed with glycerol-3-phosphate was
much higher than that seen with any other substrate. This primarily
reﬂects the very high level of glycerol-3-phosphate dehydrogenase
in brown-fat mitochondria [35,38,52]. An issue is whether such
high rates would ever be relevant in-vivo. This is doubtful, as the
rates reported here are observed with 5 mM concentrations of
glycerol-3-phosphate. Measurements of tissue levels of glycerol-3-
phosphate imply much lower levels of cytosolic glycerol-3-phosphate
(≈0.2 mM) [53,54]. Thus, in reality the brown-fat mitochondria may
not become exposed to the very high ROS levels observed with the
high glycerol-3-phosphate concentrations experimentally used.
4.1.2. Succinate
Concerning succinate-supported ROS production, we obtained ex-
actly the type of results that would be predicted from many similar
studies in other cell types. When reverse electron ﬂow was allowed,
membrane potential-sensitive ROS production could be demonstrated,
which was thus also sensitive to the activity of UCP1. This is also what
has been observed by others working with brown-fat mitochondria
[2]. However, this ROS production is supported by what are probably
high concentrations of exogenously added succinate; there are indica-
tions that endogenous succinate concentrations (from the citric acid
cycle) may be much lower [13,55,56]. Thus, had succinate been a
“typical” substrate, there would have been good evidence for UCP1
and uncoupling as protectors against enhanced ROS production and
oxidative damage. However, since succinate represents the exception
rather than the rule, the results obtained with succinate cannot be
extrapolated to be relevant for ROS production in general.
4.1.3. Acyl-CoA/acyl-carnitine
We found no effect of the presence or activity of UCP1 on ROS pro-
duction supported by the palmitoyl-CoA. In contrast, Oelkrug et al. [2]
suggested that UCP1 mitigates mitochondrial superoxide production
during fatty acid oxidation. This was based on experiments different
from those used here and of a somewhat more complex type. First
Oelkrug et al. [2] ran what is traditionally referred to as a “carnitine
cycle” in brown-fat mitochondria from wildtype and UCP1(−/−)
mice. During this ATP-induced oxidation of endogenous fatty acids,
more ROS was produced in the UCP1(−/−) than in wildtype mice.
While this would be in accordance with UCP1 activity diminishing
ROS production, another possibility would be that the difference could
be due to different amounts of endogenous fatty acids being present
in the two types of mitochondria. We have observed that UCP1(−/−)
brown-fat mitochondria contain more fatty acids than do wildtype mi-
tochondria (not shown), and the difference in ROS production may ad-
equately be explained based on this difference in amount of substrate.
Oelkrug et al. [2] further found that addition of palmitate to the mito-
chondria enhanced ROS production more in UCP1(−/−) mitochondria
than in wildtype mitochondria. However, palmitate addition to the
UCP1(−/−) mitochondria seemed to decrease the respiratory rate, and
electronsmay accumulate in Complex-I due to limitations in electron
ﬂow (cf. our Figs. 5B and 6B). In our conditions, we see no effect of
the presence or amount of UCP1 on ROS production (Figs. 5B and 6B).
If it is accepted that only reverse electron ﬂow is sensitive to
membrane potential [41,42], and fatty acid oxidation does not support
reverse electron ﬂow [57], our results of lack-of-effect of UCP1 on
palmitoyl-CoA-supported ROS production would indeed be the ex-
pected outcome. Our ﬁndings of UCP1-independence of palmitoyl-
CoA-supported ROS are also principally in agreement with those of
Schönfeld et al. [5] that suggested that acylcarnitine-supported ROS
generation in brown-fat mitochondria is mainly associated with
acyl-CoA dehydrogenase and electron transferring ﬂavoprotein-
ubiquinone reductase, rather than with the central complexes of therespiratory chain. Still, it is in the form of external substrates that elec-
trons are fed into the respiratory chain, and if alterations in membrane
potential should alter physiologically relevant ROS production rates,
these effects must be observable when the relevant substrates are
made available to the mitochondria.
Thus, the indications are that acyl-CoA-supported ROS production is
independent of UCP1 activity in brown-fat mitochondria. There are,
however, further implications of these observations. Fatty acids are un-
doubtedly a major substrate source for brown-fat mitochondria in-situ,
and the implication from the present investigations would therefore be
that there is no reason to think that UCP1 activity in-situ should affect
the risk for oxidative damage in brown-fat mitochondria. Indeed, we
have observed that, as compared with wildtype mice, there is no in-
crease in HNE/protein adducts in brown-fat mitochondria isolated
from UCP1(−/−) mice, irrespective of whether they were adapted to
thermoneutral temperature (30 °C) or to the cold (4 °C) [3]. The ab-
sence of oxidative damage in UCP1(−/−) mitochondria was not due
to enhanced activity of antioxidant enzymes [3]. There was also no dif-
ference in phospholipid fatty acyl composition in brown-fat mitochon-
dria between wildtype and UCP1-ablated mice [58] in contrast that
would be expected if lipid peroxidation was activated due to absence
of UCP1.
Thus, the present and the earlier observations converge to indicate
that UCP1 would appear not to be physiologically involved in defence
against oxidative stress.
Additionally, as mentioned above, mitochondrial oxidation of
complex-I-linked substrates is the only source for succinate in-situ.
Succinate being the only substrate with a demonstrated membrane
potential effect on ROS production, any ROS originating from succinate
oxidation should be visible in the ROS production observed during acyl-
CoA oxidation. No part of the ROS production was, however, affected
by the membrane potential when acyl-CoA was the substrate. Thus,
despite the accumulation of biochemically convincing evidence for
decreased ROS production due to decreased membrane potential
when succinate is solely used as substrate, these observations can clearly
not be extrapolated to physiological circumstances.
4.1.4. Pyruvate
We found no effect of UCP1 presence or activity on ROS production
supported by pyruvate. Our results are in agreement with [2,4],
and principally this is as expected, based on the conclusions by Brand
and by Murphy that forward electron ﬂow supported by pyruvate is
insensitive to membrane potential [41,42]. However, when Dlaskova
et al. [1] used Amplex Red (as we did here), they observed UCP1 depen-
dence. These data are difﬁcult to reconcile with ours and others [2,4].
One reason for this discrepancymaybe related to the experimental con-
ditions. As pointed out earlier [7], UCP1(−/−) mitochondria are very
sensitive to medium tonicity and the low tonicity medium used by
Dlaskova et al. [1] may have inﬂuenced the results.
The reasoning above concerning acyl-CoA-supported ROS produc-
tion is equally relevant for pyruvate-supported ROS production, with
the addition that the very low rates of ROS production observed with
this substrate (about 100-fold lower than with glycerol-3-phosphate)
would indicate that pyruvate-supported ROS production may not be a
quantitatively important contributor to ROS in the cell. Thus, our data
again imply that uncoupling activity has no effect on ROS production
with physiological substrates.
4.2. Possible misleading effects of GDP
In several types of experiments, we observed that the addition of
GDP to themitochondria increased ROS production. The obvious expla-
nationwould be that this was caused by GDP inhibition of UCP1, leading
to an increase in the membrane potential and an ensuing increase in
ROS production. Indeed, this is probably what happens when
succinate-supported ROS production is followed, as in Fig. 3D. However,
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for most GDP stimulation observed here. We see effects of GDP even in
UCP1(−/−) mitochondria, and these effects are not accompanied by
(further) increases in membrane potential, eliminating the possibility
that GDP could inhibit any other “uncoupling”(-like) protein. We have
also observed such ROS production-stimulating effect of GDP in liver
mitochondria, i.e. mitochondria that do not possess any of the named
“uncoupling” proteins (not shown).
GDP could interact with other membrane proteins, such as the
adenine nucleotide transporter [59,60], but again, the effects we
saw were not paralleled with any membrane potential effects
which could have been anticipated if the adenine nucleotide trans-
porters are responsible for a signiﬁcant fraction of the “basal proton
leak” of the mitochondria [61,62]. Suski et al. found [63] effects of
GDP on ROS production in brain mitochondria — but they were in-
hibitory and are thus not relevant for the discussion here. Others
have seen very varying effects of GDP on ROS production in thymusmi-
tochondria [64], and there is indeed good reason to think that GDP can
interact in different ways with many processes.
What we conclude from all observations of GDP and ROS produc-
tion is that although GDP effects may be observable and may even in
some cases be truly due to UCP1 inhibition, the observation that GDP
has an effect can in no way be taken in general as a demonstration
that UCP1 (or any so-called uncoupling protein) is involved in the
process, at least not in a way related to mitochondrial membrane po-
tential control.4.3. The relationship between membrane potential and ROS production in
brown-fat mitochondria
In this paper, we have a series of conditions where the membrane
potential of the mitochondria is decreased (Figs. 1B, 3E, 5D) but
where parallel measurements of ROS production do not indicate
any effect of this depolarization (Figs. 1D, G, I, 3A, 5B). Taken togeth-
er, these results imply that the mitochondrial membrane potential is
of minor signiﬁcance for controlling mitochondrial ROS production.
The further implication of this would be that protection against oxi-
dative damage cannot be obtained by reduction in membrane poten-
tial, at least not in brown-fat mitochondria. This may mainly be
because most ROS is released from enzymes (dehydrogenases)
slightly distant from the core respiratory chain. However, this
does not alter the conclusion that alterations in membrane poten-
tial do not markedly affect ROS production.4.4. The signiﬁcance of UCP1 for ROS production in brown adipose tissue
The data presented here – and most of the data presented else-
where – arrive at the conclusion that UCP1 is not a regulator of ROS
production in brown-fat mitochondria; we have not been able to
replicate the few data claiming the opposite. Indeed, it has been
pointed out by Mailloux et al. [4] that the increased level of UCP1
in the cold is actually associated with a higher ROS production (cf.
also our Fig. 6). We have examined the literature to establish the re-
lationship between increased UCP1 amounts and the activation of
other protective means (which would be expected to be less needed
if UCP1 was active). Although cold acclimation is a situation with in-
creased amounts of UCP1 [65], the antioxidant system of brown adi-
pose tissue is signiﬁcantly upregulated in the cold [4,66,67]. We have
also observed signiﬁcant upregulation of SOD2 and thioredoxin re-
ductase 2 in brown-fat mitochondria isolated from cold-acclimated
mice (G. Mathy, I. Shabalina, J. Nedergaard, F. Sluse, unpublished ob-
servations). Thus, even if UCP1 would have any effect against oxida-
tive damage, it is clearly not so that the tissue would rely solely on
this for protection.4.5. The general signiﬁcance of uncoupling proteins for protection against
oxidative damage
In a broader context, this investigation of the signiﬁcance of UCP1 for
ROSproduction also constitutes a general investigation of the possibility
that other uncoupling proteins (or other proteins that could have
uncoupling characteristics) could function as ameliorators of oxidative
damage. For this thesis, observations of positive effects of UCP1 could
have been seen as a proof-of-principle. As the data presented here arrive
at the opposite conclusion, i.e. that UCP1 through membrane depolari-
zation has little ability to protect against oxidative damage, suggestions
that other UCPs could be protective by mediating uncoupling appear
less relevant. Several suggestions have been made for the existence of
agents that could activate an uncoupling activity in other UCPs [9,15];
the validity of such agents has been questioned [3,8,28,68,69]. However,
based on extrapolation of the data presented here, this issue would
be of less interest — in that even if activated, the UCPs could not be
expected to affect ROS production and oxidative damage through
an uncoupling activity.
Of course, the present observations do not exclude the possibility
that UCP1 or other UCPs may be able to protect against oxidative dam-
age through other means. Indeed, several such suggestions have been
made [69–72]. What is demonstrated here is merely that innate
uncoupling (as mediated through UCP1) at physiological conditions
does not seem to have the potential to decrease ROS production and ox-
idative damage, at least not in brown-fat mitochondria.
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